Skip to main content
Log in

Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis

  • Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Relapsing polychondritis (RP) is a rare systemic inflammatory disease primarily affecting the ears, nose and tracheobronchial tree cartilage, but also the cardiovascular system. Cardiovascular complications are the second cause of mortality in RP. We report the case of a woman with a corticosteroid-resistant RP-associated aortitis, who was successfully treated with tocilizumab (TCZ). The FDG-PET/CT was a useful tool for diagnosing aortitis and assessing the effect of biotherapy. We conducted a systematic literature review confirming this is the first case of rapid and sustained remission in a patient with corticosteroid-resistant RP-associated aortitis after TCZ treatment administered as a first-line immunotherapy. However, further studies are needed to confirm the beneficial effect of TCZ used in this life-threatening condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Le Besnerais M, Arnaud L, Boutémy J et al (2017) Aortic involvement in relapsing polychondritis. Jt Bone Spine Rev Rhum. doi:10.1016/j.jbspin.2017.05.009

    Google Scholar 

  2. Mathian A, Miyara M, Cohen-Aubart F et al (2016) Relapsing polychondritis: a 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol 30:316–333. doi:10.1016/j.berh.2016.08.001

    Article  PubMed  Google Scholar 

  3. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409–1417. doi:10.1007/s00296-011-1999-3

    Article  PubMed  Google Scholar 

  4. Hazra N, Dregan A, Charlton J et al (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology 54:2181–2187. doi:10.1093/rheumatology/kev240

    PubMed  Google Scholar 

  5. Michet CJ, McKenna CH, Luthra HS, O’Fallon WM (1986) Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104:74–78

    Article  PubMed  Google Scholar 

  6. Del Rosso A, Petix NR, Pratesi M, Bini A (1997) Cardiovascular involvement in relapsing polychondritis. Semin Arthritis Rheum 26:840–844

    Article  PubMed  Google Scholar 

  7. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the mayo clinic records - Mayo Clinic Proceedings. http://www.mayoclinicproceedings.org/article/S0025-6196(11)61731-X/pdf. Accessed 24 July 2017

  8. Shimizu J, Oka H, Yamano Y et al (2016) Cardiac involvement in relapsing polychondritis in Japan. Rheumatol Oxf Engl 55:583–584. doi:10.1093/rheumatology/kev320

    Article  Google Scholar 

  9. Rousselin C, Pontana F, Puech P, Lambert M (2016) Differential diagnosis of aortitis. Rev Med Int 37:256–263. doi:10.1016/j.revmed.2016.02.002

    Article  CAS  Google Scholar 

  10. Arnaud L, Mathian A, Haroche J et al (2014) Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev 13:90–95. doi:10.1016/j.autrev.2013.07.005

    Article  CAS  PubMed  Google Scholar 

  11. Ouchi N, Uzuki M, Kamataki A et al (2011) Cartilage destruction is partly induced by the internal proteolytic enzymes and apoptotic phenomenon of chondrocytes in relapsing polychondritis. J Rheumatol. doi:10.3899/jrheum.101044

  12. Stabler T, Piette J-C, Chevalier X et al (2004) Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50:3663–3667. doi:10.1002/art.20613

    Article  CAS  PubMed  Google Scholar 

  13. Ohwatari R, Fukuda S, Iwabuchi K et al (2001) Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener’s granulomatosis and relapsing polychondritis. Ann Otol Rhinol Laryngol 110:1035–1040. doi:10.1177/000348940111001108

    Article  CAS  PubMed  Google Scholar 

  14. Wallace ZS, Stone JH (2013) Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade. J Rheumatol 40:100–101. doi:10.3899/jrheum.120381

    Article  PubMed  Google Scholar 

  15. Kawai M, Hagihara K, Hirano T et al (2009) Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Rheumatol Oxf Engl 48:318–319. doi:10.1093/rheumatology/ken468

    Article  CAS  Google Scholar 

  16. Yamashita H, Takahashi H, Kubota K et al (2014) Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review. Rheumatology 53:1482–1490. doi:10.1093/rheumatology/keu147

    Article  PubMed  Google Scholar 

  17. Lei W, Zeng H, Zeng D-X et al (2016) (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol 89:20150695. doi:10.1259/bjr.20150695

    Article  PubMed  Google Scholar 

  18. Wang J, Li S, Zeng Y et al (2014) 18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring. Ann Nucl Med 28:276–284. doi:10.1007/s12149-014-0805-1

    Article  CAS  PubMed  Google Scholar 

  19. Soussan M, Abisror N, Abad S et al (2014) FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev 13:125–131. doi:10.1016/j.autrev.2013.09.009

    Article  PubMed  Google Scholar 

  20. Selim AG, Fulford LG, Mohiaddin RH, Sheppard MN (2001) Active aortitis in relapsing polychondritis. J Clin Pathol 54:890–892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rho YH, Choi SJ, Choi YS et al (2005) Relapsing polychondritis with aortitis without valvular involvement. J Rheumatol 32:954–956

    PubMed  Google Scholar 

  22. Yung A, Charleson HA, Ullal R, Doube A (2000) A case of relapsing polychondritis with coronary ostial stenosis and severe aortic incompetence. Semin Arthritis Rheum 30:144–146

    CAS  PubMed  Google Scholar 

  23. Walker UA, Weiner SM, Vaith P et al (1998) Aortitis in relapsing polychondritis. Br J Rheumatol 37:1359–1361

    Article  CAS  PubMed  Google Scholar 

  24. Barretto SN, Oliveira GH, Michet CJ et al (2002) Multiple cardiovascular complications in a patient with relapsing polychondritis. Mayo Clin Proc 77:971–974. doi:10.4065/77.9.971

    Article  PubMed  Google Scholar 

  25. Sugrue G, Durcan L, Bell L et al (2014) Unsuspected cardiovascular involvement in relapsing polychondritis: a case of aortitis with critical coronary artery stenosis secondary to relapsing polychondritis. Circ Cardiovasc Imaging 7:409–411. doi:10.1161/CIRCIMAGING.113.001290

    Article  PubMed  Google Scholar 

  26. Marie I, Lahaxe L, Josse S, Levesque H (2009) Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement. Rheumatology 48:1328–1329. doi:10.1093/rheumatology/kep224

    Article  PubMed  Google Scholar 

  27. Seymour MW, Home DM, Williams RO, Allard SA (2007) Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. Rheumatology 46:1738–1739. doi:10.1093/rheumatology/kem229

    Article  CAS  PubMed  Google Scholar 

  28. Sallés M, Mínguez S, Ros S et al (2017) Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis. Clin Exp Rheumatol 35(Suppl 103):223

    PubMed  Google Scholar 

  29. Stael R, Smith V, Wittoek R et al (2015) Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review. Clin Rheumatol 34:189–193. doi:10.1007/s10067-014-2670-7

    Article  PubMed  Google Scholar 

  30. Narshi CB, Allard SA (2012) Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis. Rheumatology 51:952–953. doi:10.1093/rheumatology/ker451

    Article  CAS  PubMed  Google Scholar 

  31. Loricera J, Blanco R, Castañeda S et al (2014) Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol 32:S79–S89

    PubMed  Google Scholar 

  32. Risse J, Mandry D, Settembre N et al (2016) Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease. Circ Cardiovasc Imaging. doi:10.1161/CIRCIMAGING.116.004819

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Jonathan London (Department of Internal Medicine, Hospital Cochin, Université Paris-5, Paris, France) for his critical review of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sébastien Abad.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Financial support statement

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elourimi, G., Soussan, M., Warzocha, U. et al. Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis. Rheumatol Int 37, 1931–1935 (2017). https://doi.org/10.1007/s00296-017-3832-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3832-0

Keywords

Navigation